Toxicologic effects of ribavirin in cats

Journal of Veterinary Pharmacology and Therapeutics - Tập 16 Số 3 - Trang 301-316 - 1993
Richard C. Weiss1, Nancy R. Cox, Mary K. Boudreaux
1Scott-Richey Research Center, AL.

Tóm tắt

Ribavirin, a broad‐spectrum antiviral agent active in vitro against a number of RNA and DNA viruses, has been associated with moderate toxicity in laboratory animals and humans. Clinically, ribavirin has been used effectively in persons primarily to treat life‐threatening viral diseases such as acute haemorrhagic fever or viral pneumonia of infants. In order to evaluate the feasibility of using this antiviral agent in cats, the effects of oral (p.o.), intramuscular (i.m.) and intravenous (i.v.) doses of ribavirin in 27 9‐month‐old specific‐pathogen‐free cats were evaluated by haematology, clinical chemistries, bone marrow biopsies and histopathology. Ribavirin was administered once daily for 10 consecutive days at a dose of either 11, 22, or 44 mg/kg after which all cats were euthanatized and necropsied. Most cats receiving 22 or 44 mg of ribavirin/kg became anorectic and suffered some degree of weight loss (0.2 to 0.6 kg), and about one‐third of the cats developed diarrhoea and/or mucous membrane pallor. Icterus or haemorrhage was not observed. The most profound and consistent haemato‐logic change, particularly among the moderate and high dosage groups regardless of route of administration, was a significant and severe thrombocytopenia (range, 33–78% reduction in mean platelet counts vs. baseline). Other changes, particularly reductions in total WBC and neutrophils and reductions in RBC and PCV, tended to occur at lower ribavirin dosages, but generally they were not statistically significant. Cats given 44 mg of ribavirin/kg i.v. showed significant decreases in leukocyte variables, including total WBC (P = 0.016), neutrophils (P= 0.026) and lymphocytes (P= 0.047). Mild‐to‐moderate increases in serum alanine aminotransferase and alkaline phosphatase activities occurred at doses of 22 and 44 mg/kg. Evaluation of bone marrow biopsies before and after treatment revealed that cats given 11 mg of ribavirin/kg had mild megakaryocytic (MK) hypoplasia, whereas cats receiving 22 or 44 mg/kg had progressively severe degrees of MK hypoplasia and dysplasia, asynchronous MK maturation, and increased myeloidrerythroid ratio. Pathologic changes in ribavirin‐treated cats generally were mild and included primarily enteritis (seven cats) and hepatocellular vacuolation and/or centrilobular necrosis (seven cats). Results of this study in cats indicated that daily administration of ribavirin at a dose range of 11 to 44 mg/kg induced a dose‐related toxic effect on bone marrow, primarily on megakaryocytes and erythroid precursors, and at the higher dosages it suppressed numbers of circulating leukocytes.

Từ khóa


Tài liệu tham khảo

10.1016/0163-7258(83)90010-4

Bodsworth N., 1990, Ribavirin: A role in HIV infection, Journal of Acquired Immune Deficiency Syndromes, 3, 893

10.1016/S0190-9622(88)70031-6

Canonico P.G., 1983, Ribavirin: A review of efficacy, toxicity and mechanisms of antiviral activity, Antibiotics, 4, 161

10.1016/0041-008X(84)90138-8

10.1016/0041-008X(84)90139-X

10.1159/000206386

10.1128/AAC.10.5.809

10.1128/AAC.7.5.582

Fernandez H., 1980, Ribavirin: A Broad Spectrum Antiviral Agent., 215

Gillett C.S., 1990, Alopecia associated with ribavirin administration in rabbits, Laboratory Animal Science, 40, 207

Hillyard I.W., 1980, Ribavirin: A Broad Spectrum Antiviral Agent., 59

10.1093/clinids/11.Supplement_4.S750

10.1016/S0140-6736(84)92060-9

Ogilvie G.K.(1991)Demystifying hematopoeitic growth factors.Proceedings of 9th American College of Veterinary Internal Medicine Forum.New Orleans LA pp.733–735.

10.1016/S0140-6736(84)90774-8

10.1016/0165-2427(89)90134-7

Povey R.C., 1978, In vitro antiviral efficacy of ribavirin against feline calicivirus, feline viral rhinotracheitis virus, and canine parainfluenza virus, American Journal of Veterinary Research, 39, 175

Povey R.C., 1978, Effect of orally administered ribavirin on experimental feline calicivirus infection in cats, American Journal of Veterinary Research, 39, 1337

10.1016/S0025-7125(16)30766-0

Roberts R.B., 1990, A multicenter clinical trial of oral ribavirin in HIV‐infected patients with lymph‐adenopathy, Journal of Acquired Immune Deficiency Syndromes, 3, 884

Sidwell R.W., 1980, Ribavirin: A Broad Spectrum Antiviral Agent., 23

Smith C.B., 1980, Ribavirin: A Broad Spectrum Antiviral Agent., 147

Weiss R.C., 1980, Disseminated intravascular coagulation in experimentally induced feline infectious peritonitis, American Journal of Veterinary Research, 40, 663

10.1016/0378-1135(89)90049-7

Weiss R.C., Evaluation of free or liposome‐encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis, Research in Veterinary Science

Thông tin
Thông tin xuất bản

Journal of Veterinary Pharmacology and Therapeutics

Tập 16 Số 3

301-316

Thông tin tác giả